Leveraging Technology to Develop New Trial Endpoints

Originally published in Applied Clinical Trials - December 2018. Click on the article image below to read.

This article reviews the "future endpoints" session chaired by Bill Byrom at this year's DIA Annual Meeting.  Bill reviews the use of wearable sensors to measure EEG activity to derive objective measures of pain; published work by researchers at Roche exploring the use of new endpoints based on remotely administered performance tests conducted using smartphones in MS patients; and work using consumer depth cameras such as Microsoft Kinect to develop new objective measures of movement.

No Previous Articles

Next
eCOA Forum 2018
eCOA Forum 2018

Two Days. 15+ eCOA expert speakers. You, your peers and an evolutionary discussion on clinical trials. eCOA...